Estados financieros detallados de ProPhase Labs, Inc. (PRPH): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
ProPhase Labs, Inc. registró ingresos de $4.3M en el último ejercicio fiscal, con un CAGR de 5 años del -21.4%.
Márgenes de los últimos 12 meses: margen bruto 16.4%, margen operativo -498.7%, margen neto -7.2%.
Al precio actual de $0.01, PRPH presenta beneficios negativos (P/E no significativo) y un ROE del -13.59%. La capitalización bursátil es de $0M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $21.0M | $9.9M | $13.1M | $9.9M | $14.5M | $79.0M | $122.6M | $44.4M | $6.8M | $4.3M |
| Coste de Ventas | $10.9M | $7.9M | $8.3M | $7.3M | $9.9M | $46.2M | $52.0M | $28.1M | $6.9M | $3.0M |
| Beneficio Bruto | $10.1M | $1.9M | $4.8M | $2.6M | $4.6M | $32.8M | $70.7M | $16.2M | -$150000 | $1.4M |
| I+D | $575000 | $431000 | $398000 | $332000 | $633000 | $520000 | $652000 | $1.4M | $594000 | $107000 |
| Generales y Administrativos | $12.1M | $5.5M | $6.0M | $5.5M | $7.9M | $22.5M | $46.4M | $34.5M | $37.9M | $19.3M |
| Gastos Operativos | $12.7M | $5.9M | $6.4M | $5.9M | $8.6M | $23.0M | $47.1M | $37.9M | $38.5M | $19.4M |
| Beneficio Operativo | -$2.7M | -$4.0M | -$1.6M | -$3.2M | -$4.0M | $9.8M | $23.6M | -$21.6M | -$38.6M | -$18.0M |
| EBITDA | -$3.4M | -$3.7M | -$1.3M | -$2.7M | -$1.5M | $11.4M | $28.7M | -$14.8M | -$32.3M | -$11.4M |
| Gastos por Intereses | $213000 | $54000 | 0 | 0 | $295000 | $1.1M | $764000 | $1.3M | $3.4M | $6.9M |
| Beneficio Antes de Impuestos | -$2.9M | -$3.7M | -$1.5M | -$3.1M | -$2.3M | $5.3M | $22.9M | -$22.4M | -$42.3M | -$23.4M |
| Impuestos | $212000 | -$18.0M | $103000 | 0 | $12000 | -$968000 | $4.4M | -$6.0M | $7.2M | 0 |
| Beneficio Neto | -$2.9M | $41.8M | -$1.7M | -$3.1M | -$2.1M | $6.3M | $18.5M | -$16.8M | -$53.4M | -$14.7M |
| BPA | $-1.70 | $26.10 | $-1.50 | $-2.60 | $-2.00 | $4.10 | $11.70 | $-9.80 | $-26.10 | $-1.74 |
| BPA Diluido | $-1.70 | $25.90 | $-1.50 | $-2.60 | $-2.00 | $4.00 | $10.20 | $-9.80 | $-26.10 | $-1.74 |
| Acciones en Circulación (Diluidas) | $1.7M | $1.6M | $1.1M | $1.2M | $1.2M | $1.8M | $1.9M | $1.7M | $1.9M | $8.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $883000 | $784000 | $478000 | $1.0M |
| Beneficio Bruto | -$123000 | $247000 | $167000 | $226000 |
| Beneficio Operativo | -$4.8M | -$5.7M | -$2.6M | -$2.6M |
| EBITDA | -$4.4M | $1.3M | -$2.4M | -$1.7M |
| Beneficio Neto | -$6.8M | -$7.4M | -$5.4M | -$3.1M |
| BPA | $-1.60 | $-0.87 | $-0.43 | $-0.22 |
| BPA Diluido | $-1.60 | $-0.87 | $-0.43 | $-0.22 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $441000 | $3.2M | $1.6M | $434000 | $6.8M | $8.7M | $9.1M | $1.6M | $678000 | $90000 |
| Inversiones a Corto | 0 | $18.8M | $6.7M | $926000 | $1.6M | $8.9M | $8.3M | $3.1M | 0 | 0 |
| Cuentas por Cobrar | $5.8M | $1.9M | $7.8M | $6.8M | $3.2M | $37.7M | $37.1M | $35.8M | $20.1M | $1.5M |
| Inventario | $2.7M | $1.5M | $1.9M | $1.5M | $3.0M | $4.6M | $4.0M | $2.3M | $1.1M | $70000 |
| Activos Corrientes | $9.6M | $28.9M | $18.2M | $9.9M | $15.9M | $61.3M | $60.8M | $47.6M | $30.6M | $3.1M |
| Inmovilizado Material | $3.2M | $2.7M | $2.5M | $2.3M | $8.3M | $10.3M | $11.3M | $14.9M | $11.6M | $2.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | $901000 | $5.7M | $5.7M | $5.2M | $5.2M | $4.0M |
| Activos Intangibles | 0 | 0 | 0 | 0 | $1.2M | $10.9M | $8.5M | $12.3M | $9.8M | $7.2M |
| Activos Totales | $12.8M | $34.2M | $20.7M | $12.3M | $31.4M | $89.3M | $87.6M | $91.9M | $63.2M | $59.9M |
| Cuentas por Pagar | $2.2M | $562000 | $437000 | $432000 | $3.8M | $7.0M | $5.9M | $8.6M | $13.7M | $13.0M |
| Deuda a Corto | $1.5M | 0 | 0 | 0 | $329000 | $663000 | $301000 | $2.8M | $6.6M | $5.2M |
| Pasivos Corrientes | $6.8M | $1.8M | $4.2M | $933000 | $6.3M | $15.5M | $16.1M | $20.9M | $32.1M | $53.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $10.0M | $10.0M | $2.4M | $7.3M | $11.7M | 0 |
| Pasivos Totales | $6.8M | $1.1M | $4.2M | $1.0M | $20.8M | $30.7M | $24.0M | $42.5M | $55.8M | $56.4M |
| Reservas | -$19.7M | $22.1M | $4.5M | -$1.5M | -$3.6M | $2.6M | $11.8M | -$5.0M | -$58.4M | -$73.1M |
| Patrimonio Neto | $6.0M | $31.8M | $16.5M | $11.2M | $10.6M | $58.6M | $63.6M | $49.4M | $7.4M | $3.5M |
| Deuda Total | $1.5M | 0 | 0 | 0 | $14.7M | $14.9M | $7.0M | $18.5M | $24.6M | $8.6M |
| Deuda Neta | $1.0M | -$21.9M | -$8.2M | -$1.4M | $6.3M | -$2.6M | -$10.5M | $13.7M | $23.9M | $8.5M |
| Capital Circulante | $2.8M | $27.1M | $14.0M | $9.0M | $9.6M | $45.8M | $44.8M | $26.7M | -$1.5M | -$49.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $405000 | $90000 | $31000 | $20000 |
| Activos Totales | $65.7M | $59.9M | $58.8M | $57.4M |
| Pasivos Totales | $58.8M | $56.4M | $59.3M | $60.5M |
| Patrimonio Neto | $6.9M | $3.5M | -$592000 | -$3.1M |
| Deuda Total | $7.7M | $8.6M | $8.9M | $9.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$2.9M | $41.8M | -$1.7M | -$3.1M | -$2.1M | $6.3M | $18.5M | -$16.8M | -$49.5M | -$23.4M |
| Amortizaciones | $426000 | $337000 | $383000 | $398000 | $458000 | $3.6M | $5.1M | $6.7M | $6.6M | $5.1M |
| Compensación en Acciones | $1000 | $78000 | $634000 | $744000 | $1.5M | $3.2M | $4.0M | $3.5M | $3.6M | $1.9M |
| Cambio en Capital Circulante | $1.9M | -$421000 | -$1.7M | $1.1M | -$608000 | -$26.9M | -$4.3M | -$5.7M | $14.9M | -$185000 |
| Flujo de Caja Operativo | -$472000 | -$2.8M | -$2.1M | -$841000 | -$2.6M | -$13.6M | $28.6M | -$11.3M | -$17.5M | -$8.3M |
| Inversiones (CapEx) | -$651000 | -$208000 | -$140000 | -$228000 | -$1.7M | -$4.2M | -$3.9M | -$3.2M | -$906000 | 0 |
| Adquisiciones | 0 | $40.8M | $140000 | $228000 | -$2.5M | -$9.1M | 0 | -$2.9M | 0 | 0 |
| Recompra de Acciones | 0 | -$16.3M | 0 | 0 | 0 | -$917000 | -$9.6M | -$6.0M | 0 | 0 |
| Dividendos Pagados | 0 | 0 | -$11.7M | -$5.8M | 0 | -$4.5M | -$9.4M | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.1M | -$3.0M | -$2.3M | -$1.1M | -$4.3M | -$17.9M | $24.6M | -$14.5M | -$18.4M | -$8.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$21.5M | -$8.3M | -$748000 | -$78000 |
| Inversiones (CapEx) | 0 | 0 | 0 | $77999 |
| Flujo de Caja Libre | -$21.5M | -$8.3M | -$748000 | -$78000 |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $431000 | $1.9M | $390000 | $375000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -53.0% | +33.0% | -24.8% | +47.0% | +444.6% | +55.2% | -63.8% | -84.7% | -35.8% |
| Crecimiento Beneficio Neto (anual) | | +1558.5% | -104.2% | -80.8% | +32.5% | +395.2% | +194.3% | -190.9% | -218.0% | +72.4% |
| Crecimiento BPA (anual) | | +1635.3% | -105.7% | -73.3% | +23.1% | +305.0% | +185.4% | -183.8% | -166.3% | +93.3% |
| Cambio en Acciones (anual) | | -8.1% | -27.4% | +1.5% | +0.3% | +58.6% | +1.4% | -7.7% | +10.9% | +344.9% |
| Crecimiento FCF (anual) | | -171.2% | +25.8% | +52.7% | -300.5% | -317.0% | +238.0% | -158.9% | -27.2% | +54.8% |
| Margen Bruto | 47.9% | 19.7% | 36.4% | 26.5% | 31.7% | 41.5% | 57.6% | 36.6% | -2.2% | 31.9% |
| Margen Operativo | -12.6% | -40.4% | -12.4% | -32.8% | -27.4% | 12.4% | 19.2% | -48.7% | -570.6% | -415.4% |
| Margen EBITDA | -16.4% | -37.2% | -9.5% | -27.4% | -10.3% | 14.4% | 23.4% | -33.4% | -477.6% | -262.3% |
| Margen Neto | -13.6% | 423.9% | -13.3% | -31.9% | -14.6% | 7.9% | 15.1% | -37.8% | -788.2% | -339.3% |
| Margen FCF | -5.3% | -30.9% | -17.2% | -10.8% | -29.5% | -22.6% | 20.1% | -32.7% | -272.4% | -192.0% |
| Tasa Impositiva Efectiva | -7.4% | 491.1% | -7.0% | -0.0% | -0.5% | -18.2% | 19.4% | 26.9% | -17.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.66 | $-1.94 | $-1.98 | $-0.92 | $-3.69 | $-9.70 | $13.21 | $-8.43 | $-9.67 | $-0.98 |
| Dividendo por Acción | $0.00 | $0.00 | $10.27 | $5.03 | $0.00 | $2.47 | $5.01 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.7M | $1.6M | $1.1M | $1.2M | $1.2M | $1.5M | $1.6M | $1.7M | $1.9M | $8.5M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -1358.66% |
| Rentabilidad sobre capital invertido | -188.35% |
| Rentabilidad sobre activos | -39.44% |
| Margen bruto | 16.38% |
| Margen operativo | -498.73% |
| Margen neto | -717.43% |
Salud financiera
| Deuda / Patrimonio | -2.93 |
| Ratio corriente | 0.05 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -23.53 | 1.66 | -42.00 | -15.15 | -22.95 | 8.76 | 4.12 | -2.31 | -0.29 | -0.26 |
| P/VC | 11.20 | 2.12 | 4.35 | 4.06 | 5.04 | 0.93 | 1.20 | 0.79 | 1.96 | 1.09 |
| P/V | 3.18 | 6.85 | 5.47 | 4.61 | 3.67 | 0.69 | 0.62 | 0.88 | 2.13 | 0.88 |
| Margen Bruto | 47.9% | 19.7% | 36.4% | 26.5% | 31.7% | 41.5% | 57.6% | 36.6% | -2.2% | 31.9% |
| Margen Operativo | -12.6% | -40.4% | -12.4% | -32.8% | -27.4% | 12.4% | 19.2% | -48.7% | -570.6% | -415.4% |
| Margen Neto | -13.6% | 423.9% | -13.3% | -31.9% | -14.6% | 7.9% | 15.1% | -37.8% | -788.2% | -339.3% |